Pharmaceutical Marketing Ethics Commission supervises companies’ compliance with the Code of Ethics for Pharmaceutical Marketing governing pharmaceutical marketing and relations with health care professionals as well as relations between the pharmaceutical industry and patient organisations. The Commission ensures that pharmaceutical industry subjects and non-industry complaints are processed in the same manner, without regard to who has made the complaint.

The Pharmaceutical Marketing Ethics Committee is responsible for organizing the Commission’s activities, Supervision of the Code, including advice, comments and guidelines related to the applicability and improvement of the Code, analyzing the reports submitted regarding the breaches of the Code, imposition and enforcement of sanctions for the violations of the Code.


Commission is elected for 2 years period and is composed of 7 members – the independent chairperson, 3 members delegated by IFPA, and 3 members delegated by VGA.

Pharmaceutical Marketing Ethics Commission:


dr. Konradas Vitkevičius


Mindaugas Grinevičius, Sandoz Pharmaceuticals d.d. Branch


Jurga Stephenson

UAB “GlaxoSmithKline Lietuva”

Alina Tikuišienė

UAB „Bayer“

Vilma Prialgauskienė

UAB „Sicor Biotech“

Mindaugas Papievis

UAB „Servier Pharma”

Darius Staugaitis

Medochemie representative office